VHT Among Health Care ETFs
End-of-day Nov 16, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.7% | −0.7% | +5.6% | +8.7% | +21.3% | +23.7% | +59.3% | +43.1% | +728.3% |
| Peer average | −1.5% | −3.2% | +4.0% | +1.6% | +19.6% | +25.3% | +73.9% | +24.7% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$147 of every $1,000 in VHT is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly | Healthcare | 14.66% | $1,466.27 | 2.5M | $3.48B |
| 2 | JNJJohnson & Johnson | Healthcare | 8.38% | $838.30 | 7.3M | $1.99B |
| 3 | ABBVAbbVie | Healthcare | 6.73% | $673.23 | 5.4M | $1.60B |
| 4 | UNHUnitedHealth Group | Healthcare | 4.78% | $477.59 | 2.8M | $1.13B |
| 5 | MRKMerck | Healthcare | 4.77% | $477.19 | 7.6M | $1.13B |
| 6 | TMOThermo Fisher Scientific | Healthcare | 3.35% | $334.71 | 1.1M | $795.4M |
| 7 | AMGNAmgen | Healthcare | 3.25% | $325.00 | 1.7M | $772.4M |
| 8 | GILDGilead Sciences | Healthcare | 2.74% | $273.84 | 3.8M | $650.8M |
| 9 | ABTAbbott Laboratories | Healthcare | 2.39% | $239.02 | 5.3M | $568.0M |
| 10 | PFEPfizer | Healthcare | 2.25% | $224.78 | 17.5M | $534.2M |
| 11 | ISRGIntuitive Surgical | Healthcare | 1.98% | $197.73 | 1.1M | $469.9M |
| 12 | DHRDanaher | Healthcare | 1.91% | $191.16 | 2.0M | $454.3M |
| 13 | VRTXVertex Pharmaceuticals | Healthcare | 1.83% | $183.30 | 779K | $435.6M |
| 14 | BMYBristol-Myers Squibb | Healthcare | 1.65% | $164.88 | 6.3M | $391.8M |
| 15 | MDTMedtronic | Healthcare | 1.60% | $159.67 | 3.9M | $379.5M |
of the $114B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly & | 14.66% |
| 2 | JNJ | Johnson & Johnson | 8.38% |
| 3 | ABBV | AbbVie | 6.73% |
| 4 | UNH | UnitedHealth Group | 4.78% |
| 5 | MRK | Merck & | 4.77% |
| 6 | TMO | Thermo Fisher Scientific | 3.35% |
| 7 | AMGN | Amgen | 3.25% |
| 8 | GILD | Gilead Sciences | 2.74% |
| 9 | ABT | Abbott Laboratories | 2.39% |
| 10 | PFE | Pfizer | 2.25% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 23, 2026 | Sep 25, 2026 | $0.97 |
| Jun 24, 2026 | Jun 26, 2026 | $0.99 |
| Mar 24, 2026 | Mar 26, 2026 | $0.99 |
| Dec 17, 2025 | Dec 19, 2025 | $1.67 |
| Sep 24, 2025 | Sep 26, 2025 | $1.08 |
| Jun 26, 2025 | Jun 30, 2025 | $0.96 |
| Mar 25, 2025 | Mar 27, 2025 | $0.94 |
| Dec 18, 2024 | Dec 20, 2024 | $0.92 |
| Sep 27, 2024 | Oct 1, 2024 | $1.17 |
| Jun 28, 2024 | Jul 2, 2024 | $0.97 |
| Mar 22, 2024 | Mar 27, 2024 | $0.82 |
| Dec 19, 2023 | Dec 22, 2023 | $0.89 |